Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Hedge Funds > Stonepine Capital > Profile

Hedge Fund - Stonepine Capital

Timothy P. Lynch Bio, Returns, AUM, Net Worth

Manager biography is currently missing.
Timothy P. Lynch
Fund Profile
Filing Period:
Fund Name: Stonepine Capital
Manager Timothy P. Lynch
Portfolio Value $231,228,198
Change This QTR +0.77%
Fund Holdings Sector Distribution
Top 13F Holdings
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1.
Evolus Inc.
 EOLS 5,333,004 $56,156,532 +3% 24.28%
2.
Adma Biologics Inc.
 ADMA 9,222,617 $41,686,229 +2% 18.02%
3.
Amylyx Pharmaceuticals Inc.
 AMLX 2,500,000 $36,800,000 -1% 15.91%
4.
Quidelortho Corp
 450,000 $33,165,000 -32% 14.34%
5.
Alimera Sciences Inc
 ALIM 3,999,459 $17,277,663 +1% 7.47%
News, Interviews and Investor Letters
See All
Timothy P. Lynch's Stonepine Capital Portfolio: Top 10 Healthcare Stocks

Timothy P. Lynch's Stonepine Capital Portfolio: Top 10 Healthcare Stocks

In this article, we discuss the top 10 healthcare stock picks of Timothy P. Lynch's Stonepine Capital. If you want to skip our detailed analysis of these stocks, go directly to Timothy P.

Keep Reading →

December 11th, 2021 - Hedge Funds News

10 Pharmaceutical Stocks to Buy According to Timothy Lynch's Stonepine Capital

10 Pharmaceutical Stocks to Buy According to Timothy Lynch's Stonepine Capital

In this article, we take a look at the 10 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital.

Keep Reading →

October 14th, 2021 - Hedge Funds News

4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)

4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)

Timothy P. Lynch’s Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies.

Keep Reading →

October 26th, 2020 - Hedge Fund Analysis Hedge Funds News

Click here to See All News
Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)